IRIDEX (IRIX) CFO buys 500 shares at $1.40 — Form 4 filed

Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported an insider purchase of common stock.

Rhea-AI Filing Summary

Romeo R. Dizon, Chief Financial Officer of IRIDEX Corp (IRIX), reported an insider purchase of common stock. On 09/08/2025 he acquired 500 shares at $1.40 per share, increasing his reported beneficial ownership to 56,250 shares. The Form 4 was signed on 09/09/2025 by an attorney-in-fact.

Positive

• Insider purchase disclosed: The CFO reported acquiring 500 shares, showing ownership activity and disclosure compliance
• Clear transaction details: Transaction date, price ($1.40) and post-transaction beneficial ownership (56,250 shares) are provided

Negative

• Small transaction size: Purchase of 500 shares is modest and unlikely to be materially impactful
• No additional context: Form 4 provides no explanation of intent or plan for the purchase beyond the transaction record

Insights

Securities Analyst

TL;DR: CFO bought a small block of 500 IRIX shares at $1.40, a routine insider purchase with limited market impact.

The reported transaction is a non-derivative purchase of 500 common shares by the company's Chief Financial Officer. The acquisition price of $1.40 and the post-transaction beneficial ownership of 56,250 shares are explicitly stated. Given the modest size of the purchase relative to total shares outstanding typically associated with public companies, this filing is unlikely to be materially impactful to valuation or market dynamics. The filing was executed by an attorney-in-fact and dated 09/09/2025.

Corporate Governance Expert

TL;DR: Disclosure is timely and complete for the reported purchase; no governance concerns evident from this Form 4 alone.

The Form 4 identifies the reporting person, role as Chief Financial Officer, transaction date (09/08/2025), transaction code (P for purchase), share amount (500) and price ($1.40). It also lists the resulting beneficial ownership (56,250 shares). The form is signed by an attorney-in-fact on 09/09/2025, which is an acceptable execution method. There are no indications of amendments, derivative transactions, or other red flags in the provided content.

Insider Trade Summary

Net Buyer: 500 shares

Net Buy 1 txn

Insider Dizon Romeo R

Role Chief Financial Officer

Bought 500 shs ($700.00)

Type	Security	Shares	Price	Value
Purchase	Common Stock	500	$1.40	$700.00

Holdings After Transaction: Common Stock — 56,250 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IRIX insider Romeo R. Dizon report on the Form 4?

He reported a non-derivative purchase of 500 common shares of IRIDEX Corp on 09/08/2025 at a price of $1.40 per share.

What is Romeo R. Dizon's role at IRIDEX Corp (IRIX)?

The Form 4 lists Romeo R. Dizon as the company's Chief Financial Officer.

How many IRIX shares did Dizon beneficially own after the transaction?

The filing reports 56,250 shares beneficially owned following the reported purchase.

When was the Form 4 signed and who signed it?

The document was signed on 09/09/2025 by Nilo De Castro, Attorney-in-fact for Romeo R. Dizon.

Was the reported transaction a derivative or non-derivative trade?

It was a non-derivative purchase of common stock, indicated by transaction code P.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/09/2025 - 11:38 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		P		500	A	$1.4	56,250	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.